Susan Berg updated profile

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

In case you forgot an updated profile of:
Susan Berg has been a healthcare professional and educator for over 20 years. She was the, activity director, of many years, at Hunt Nursing and Rehabilitation Center in Danvers. While there, she has gained much dementia care and activity experience and knowledge. Now Susan consults with those needing advice about caring for those with Alzheimer's disease or a related dementia. She has had special training in dementia care and dementia activities through the Alzheimer’s Association and other educational forums. Berg is the author of Adorable Photographs of Our Baby-Meaningful, Mind-Stimulating Activities and More for the Memory Challenged, Their Loved Ones, and Involved Professionals, a book for those with dementia and an excellent resource for caregivers and healthcare professionals. You may visit at her blog at http://dementiaviews.blogspot.com or http://activitiesdirector.blogspot.com

She also writes for Activity Director Today and Alzheimer's Care Guide Magazine

A protein that protects against Alzheimer's?

e! Science News
Research on the mechanisms involved in neurodegenerative diseases such as Alzheimer's, stroke, dementia, Parkinson's and multiple sclerosis, to name a few, has taken a step forward thanks to the work of biological sciences Ph.D. student Sonia Do Carmo, supervised by Professor Éric Rassart of the Université du Québec à Montreal (UQAM) Biological Sciences Department, in collaboration with researchers at the Armand-Frappier Institute and the University of Valladolid in Spain. Do Carmo and her collaborators have successfully demonstrated the protective and reparative role of apolipoprotein D, or ApoD, in neurodegenerative diseases. Their discovery suggests interesting avenues for preventing and slowing the progression of this type of illness.

These studies were inspired by work done ten years ago by Professor Rassart's team, who then discovered increased levels of ApoD in the brains of people with several types of neurodegenerative disorders, including Alzheimer's. The team hypothesized that this protein might play a protective and restorative role but were....read the whole story
Click here for more dementia information

For outstanding dementia activities, click here

Axona, a new drug for Alzheimer's

Alzheimer's and dementia weekly
Axona is a new medical food product for the clinical dietary management of mild-to-moderate Alzheimer's Disease (AD). Axona has been shown in randomized, placebo controlled clinical trials to safely improve cognitive function and memory in patients diagnosed with mild-to-moderate AD. It will be marketed as an adjunctive therapy to currently approved AD drugs. Axona will be administered under physician supervision and dispensed by prescription, in accordance with applicable FDA regulations.

Axona provides........read the whole article

Foe more dementia information, click here

For ASlzheimer's and dementia activities, click here

Good News, Bad News on Alzheimer's Prevention

Psychiatric News
Clinical & Research News

Joan Arehart-Treichel
If avoiding Alzheimer's is one of your priorities, you might consider discarding your ginkgo tablets and enrolling in a continuing medical education course.

Many Americans believe that use of the herb Ginkgo biloba can help stave off development of Alzheimer's disease. However, results from a large clinical trial are sure to disappoint ginkgo proponents.

The trial, headed by Steven DeKosky, M.D., of the University of Virginia and a leading Alzheimer's scientist, was conducted at five academic medical centers throughout the United States. It included more than 3,000 community volunteers aged 75 or older with either normal cognition or mild cognitive impairment. It used a randomized, placebo-controlled, double-blind design.
Half the subjects took 120 mg of ginkgo twice a day, and half took a placebo twice a day. Subjects were evaluated every six months for dementia over the following six years. At the end of the six years, 523 subjects had developed dementia—277 in the ginkgo group and 246 in the placebo group.

Moreover, when the researchers looked to see whether.....read the whole article

For more dementia information, click here

Amazing dementia activities can be found here